Lenz M
Radiologische Klinik, Universität Tübingen Abteilung für Radiologische Diagnostik.
Rontgenblatter. 1990 Jun;43(6):270-81.
Standardisation of the examination method is imperative to guarantee reproducible and valid assessability of the cervical lymph node status. To this end, update high-resolution CT equipment of the third generation will be suitable, provided it meets certain minimum requirements, such as: 120 kV, 280 mAs, 480 projections over 360 degrees, 4-5 mm slice thickness, continuous tomography. If a primary tumour is known to exist, no plain examination is needed. The decisive examination is effected after intravenous administration of contrast medium in a dosage of 2.0-2.5 ml contrast medium/kg body weight (assuming a body weight of 70 kg, this would amount to 150 ml = 45 g iodine), one-third of the total dosage to be given as bolus and two-thirds as a rapid infusion. This procedure ensures sharp definition of lymph nodes against vessels and musculature over the entire period of examination. If tumour anamnesis has been established the size of the lymph node is significant for assessing the lymph node status. Even lymph node metastases less than 15 mm can be properly identified if the structure of the lymph nodes is known and employed as a criterion (central hypodensity with rim enhancement, inhomogeneity).
检查方法的标准化对于保证颈部淋巴结状态可重复且有效的评估至关重要。为此,第三代高分辨率CT设备若能满足某些最低要求,如:120 kV、280 mAs、360度范围内480次投影、4 - 5毫米层厚、连续断层扫描,则是合适的。若已知存在原发肿瘤,则无需进行平扫检查。决定性检查在静脉注射造影剂后进行,造影剂剂量为2.0 - 2.5毫升造影剂/千克体重(假设体重70千克,这相当于150毫升 = 45克碘),总剂量的三分之一作为团注给药,三分之二作为快速输注给药。此程序可确保在整个检查期间,淋巴结相对于血管和肌肉组织有清晰的界定。如果已确定肿瘤病史,淋巴结大小对于评估淋巴结状态很重要。如果已知淋巴结结构并将其作为标准(中央低密度伴边缘强化、不均匀性),即使小于15毫米的淋巴结转移也能被正确识别。